Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors

Introduction. Hepatocellular carcinoma (HCC) is characterized by aggressive course, high lethality rate and resistance to current systemic treatment. Analysis of molecular aberrations associated with HCC pathogenesis that control biological properties of HCC allows to evaluate potential efficacy of...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Makarova, O. M. Krivtsova, M. S. Chesnokov, N. I. Lazarevich
Format: Article
Language:Russian
Published: ABV-press 2017-10-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/105
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025140794949632
author A. S. Makarova
O. M. Krivtsova
M. S. Chesnokov
N. I. Lazarevich
author_facet A. S. Makarova
O. M. Krivtsova
M. S. Chesnokov
N. I. Lazarevich
author_sort A. S. Makarova
collection DOAJ
description Introduction. Hepatocellular carcinoma (HCC) is characterized by aggressive course, high lethality rate and resistance to current systemic treatment. Analysis of molecular aberrations associated with HCC pathogenesis that control biological properties of HCC allows to evaluate potential efficacy of inhibiting certain oncogenic cascades. The present study is focused on investigation of the impact of reduced expression of the key hepatocyte differentiation regulator, HNF4α, often downregulated in HCC, that influences sensitivity of HCC cells to inhibitors  of the major oncogenic pathways mTOR, CDK4/6-pRb and ROCK.Materials and methods. Changes in cells proliferation and migration caused by HNF4А gene stable knockdown were tested in human HCC cell cultures HepG2 and Huh7 followed by examination of these cellular properties under mTOR (rapamycin), CDK4/6 (PD0332991, palbociclib) and ROCK 1/2 (Y27632) inhibitors treatment. Gene expression levels were estimated by the real-time polymerase chain reaction method (Real-Time PCR).Results. HNF4А gene knockdown alters HepG2 and Huh7 cell migration associated with E-cadherin and N-cadherin expression changes. The HNF4α repression weakens Y27632-induced blockade of HCC cells migration potential. HNF4А gene knockdown causes resistance  of Huh7 cells and increase of HepG2 cells sensitivity to rapamycin and PD0332991 that block cells migration ability.Conclusions. Expression level of HNF4α renders influence on migration of HCC cells and contributes to their sensitivity to mTOR, CDK4/6 and ROCK1/2 inhibitors’ impact on cell migration activity.
format Article
id doaj-art-ad648e77f57749b18ff25dc9974e6ad5
institution DOAJ
issn 2313-805X
2413-3787
language Russian
publishDate 2017-10-01
publisher ABV-press
record_format Article
series Успехи молекулярной онкологии
spelling doaj-art-ad648e77f57749b18ff25dc9974e6ad52025-08-20T03:00:55ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872017-10-0143839110.17650/2313-805X-2017-4-3-83-91100Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitorsA. S. Makarova0O. M. Krivtsova1M. S. Chesnokov2N. I. Lazarevich3Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia.Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; Biological Faculty, M.V. Lomonosov Moscow State University.Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia.Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; Biological Faculty, M.V. Lomonosov Moscow State University.Introduction. Hepatocellular carcinoma (HCC) is characterized by aggressive course, high lethality rate and resistance to current systemic treatment. Analysis of molecular aberrations associated with HCC pathogenesis that control biological properties of HCC allows to evaluate potential efficacy of inhibiting certain oncogenic cascades. The present study is focused on investigation of the impact of reduced expression of the key hepatocyte differentiation regulator, HNF4α, often downregulated in HCC, that influences sensitivity of HCC cells to inhibitors  of the major oncogenic pathways mTOR, CDK4/6-pRb and ROCK.Materials and methods. Changes in cells proliferation and migration caused by HNF4А gene stable knockdown were tested in human HCC cell cultures HepG2 and Huh7 followed by examination of these cellular properties under mTOR (rapamycin), CDK4/6 (PD0332991, palbociclib) and ROCK 1/2 (Y27632) inhibitors treatment. Gene expression levels were estimated by the real-time polymerase chain reaction method (Real-Time PCR).Results. HNF4А gene knockdown alters HepG2 and Huh7 cell migration associated with E-cadherin and N-cadherin expression changes. The HNF4α repression weakens Y27632-induced blockade of HCC cells migration potential. HNF4А gene knockdown causes resistance  of Huh7 cells and increase of HepG2 cells sensitivity to rapamycin and PD0332991 that block cells migration ability.Conclusions. Expression level of HNF4α renders influence on migration of HCC cells and contributes to their sensitivity to mTOR, CDK4/6 and ROCK1/2 inhibitors’ impact on cell migration activity.https://umo.abvpress.ru/jour/article/view/105hnf4αhepatocellular carcinomacancer drug testsrapamycinpalbocicliby27632
spellingShingle A. S. Makarova
O. M. Krivtsova
M. S. Chesnokov
N. I. Lazarevich
Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors
Успехи молекулярной онкологии
hnf4α
hepatocellular carcinoma
cancer drug tests
rapamycin
palbociclib
y27632
title Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors
title_full Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors
title_fullStr Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors
title_full_unstemmed Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors
title_short Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors
title_sort impact of hnf4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors
topic hnf4α
hepatocellular carcinoma
cancer drug tests
rapamycin
palbociclib
y27632
url https://umo.abvpress.ru/jour/article/view/105
work_keys_str_mv AT asmakarova impactofhnf4adisruptedexpressiononhepatocellularcarcinomacellssensitivitytooncogenicpathwaysinhibitors
AT omkrivtsova impactofhnf4adisruptedexpressiononhepatocellularcarcinomacellssensitivitytooncogenicpathwaysinhibitors
AT mschesnokov impactofhnf4adisruptedexpressiononhepatocellularcarcinomacellssensitivitytooncogenicpathwaysinhibitors
AT nilazarevich impactofhnf4adisruptedexpressiononhepatocellularcarcinomacellssensitivitytooncogenicpathwaysinhibitors